SMS Pharmaceuticals, 532815, SMSPHARMA Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

2,709.35
37.04
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

2,978.52
0.14%
3.84

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

2.50
6.81
14.46

EBITDA CAGR (%)

10 Years
5 Years
3 Years

4.53
2.79
20.58

PAT CAGR (%)

10 Years
5 Years
3 Years

4.93
2.03
158.99

P:E (Median)

8 Years
5 Years
3 Years

19.40
27.79
32.46

P:BV (Average)

8 Years
5 Years
3 Years

2.34
2.70
2.87

EV:EBITDA (Average)

8 Years
5 Years
3 Years

12.24
15.16
18.42

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 196.05 164.45 19.22% 248.20 245.80 0.98% 173.35 161.48 7.35% 196.75 166.64 18.07%
Expenses 157.19 130.99 20.00% 206.85 212.31 -2.57% 140.05 132.60 5.62% 164.89 138.82 18.78%
EBITDA 38.86 33.47 16.10% 41.35 33.49 23.47% 33.30 28.88 15.30% 31.86 27.82 14.52%
EBIDTM 19.82% 20.35% 16.66% 13.62% 19.21% 17.88% 16.19% 16.70%
Other Income 0.59 1.37 -56.93% 1.42 1.65 -13.94% 2.13 1.49 42.95% 1.31 0.81 61.73%
Interest 5.84 4.67 25.05% 5.06 5.61 -9.80% 4.20 5.95 -29.41% 4.61 5.57 -17.24%
Depreciation 9.75 8.38 16.35% 8.64 7.92 9.09% 8.70 8.01 8.61% 8.62 7.90 9.11%
PBT 23.86 21.78 9.55% 29.06 21.61 34.47% 22.53 16.41 37.29% 19.94 15.16 31.53%
Tax 5.65 5.46 3.48% 8.44 5.69 48.33% 5.36 4.24 26.42% 5.68 3.11 82.64%
PAT 18.21 16.33 11.51% 20.62 15.92 29.52% 17.17 12.17 41.08% 14.26 12.05 18.34%
PATM 9.29% 9.93% 8.31% 6.48% 9.91% 7.54% 7.25% 7.23%
EPS 2.05 1.84 11.41% 2.33 1.80 29.44% 1.94 1.37 41.61% 1.61 1.36 18.38%

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 196.05 164.45 19.22% 248.20 245.80 0.98% 173.35 161.48 7.35% 196.75 166.64 18.07%
Expenses 156.68 130.94 19.66% 207.39 212.18 -2.26% 140.14 132.48 5.78% 165.28 138.82 19.06%
EBITDA 39.37 33.51 17.49% 40.81 33.62 21.39% 33.21 29.00 14.52% 31.47 27.82 13.12%
EBIDTM 20.08% 20.38% 16.44% 13.68% 19.16% 17.96% 15.99% 16.70%
Other Income 0.59 1.37 -56.93% 1.42 1.65 -13.94% 2.13 1.49 42.95% 1.31 0.81 61.73%
Interest 5.84 4.67 25.05% 5.06 5.61 -9.80% 4.20 5.95 -29.41% 4.61 5.57 -17.24%
Depreciation 9.75 8.38 16.35% 8.64 7.92 9.09% 8.70 8.01 8.61% 8.62 7.90 9.11%
PBT 24.37 21.83 11.64% 28.52 21.74 31.19% 22.44 16.53 35.75% 19.54 15.16 28.89%
Tax 5.65 5.46 3.48% 8.44 5.69 48.33% 5.36 4.24 26.42% 5.68 3.11 82.64%
PAT 18.71 16.37 14.29% 20.08 16.05 25.11% 17.08 12.29 38.97% 13.86 12.05 15.02%
PATM 9.55% 9.96% 8.09% 6.53% 9.85% 7.61% 7.05% 7.23%
EPS 2.31 1.95 18.46% 2.29 2.04 12.25% 2.15 1.36 58.09% 1.67 1.39 20.14%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 814.35 782.75 709.26 522.05 519.87 563.18 411.95 464.91 464.93 445.49 611.53 Net Sales Growth 10.29% 10.36% 35.86% 0.42% -7.69% 36.71% -11.39% 0.00% 4.36% -27.15% Cost Of Goods Sold 459.68 436.09 424.04 335.60 275.30 340.00 246.36 292.71 289.90 295.85 385.15 Gross Profit 354.67 346.66 285.22 186.44 244.58 223.18 165.59 172.20 175.03 149.64 226.38 GP Margin 43.55% 44.29% 40.21% 35.71% 47.05% 39.63% 40.20% 37.04% 37.65% 33.59% 37.02% Total Expenditure 668.98 642.77 592.28 467.32 405.10 442.04 331.92 374.77 371.59 370.35 522.32 Power & Fuel Cost - 56.76 47.12 35.97 32.58 23.31 18.99 21.75 22.57 18.23 33.81 % Of Sales - 7.25% 6.64% 6.89% 6.27% 4.14% 4.61% 4.68% 4.85% 4.09% 5.53% Employee Cost - 69.72 56.78 50.08 51.02 41.17 39.35 35.59 32.80 26.92 38.11 % Of Sales - 8.91% 8.01% 9.59% 9.81% 7.31% 9.55% 7.66% 7.05% 6.04% 6.23% Manufacturing Exp. - 42.85 37.87 28.08 25.80 16.28 14.89 13.29 12.14 10.35 37.94 % Of Sales - 5.47% 5.34% 5.38% 4.96% 2.89% 3.61% 2.86% 2.61% 2.32% 6.20% General & Admin Exp. - 22.45 20.68 12.48 15.32 14.93 8.05 8.69 8.45 9.00 10.51 % Of Sales - 2.87% 2.92% 2.39% 2.95% 2.65% 1.95% 1.87% 1.82% 2.02% 1.72% Selling & Distn. Exp. - 13.75 4.73 3.82 3.42 5.09 3.70 2.25 4.81 9.67 15.99 % Of Sales - 1.76% 0.67% 0.73% 0.66% 0.90% 0.90% 0.48% 1.03% 2.17% 2.61% Miscellaneous Exp. - 1.17 1.07 1.27 1.67 1.25 0.58 0.49 0.91 0.33 15.99 % Of Sales - 0.15% 0.15% 0.24% 0.32% 0.22% 0.14% 0.11% 0.20% 0.07% 0.13% EBITDA 145.37 139.98 116.98 54.73 114.77 121.14 80.03 90.14 93.34 75.14 89.21 EBITDA Margin 17.85% 17.88% 16.49% 10.48% 22.08% 21.51% 19.43% 19.39% 20.08% 16.87% 14.59% Other Income 5.45 6.22 4.46 4.91 5.20 3.45 5.11 3.40 2.39 1.45 3.61 Interest 19.71 18.54 23.60 21.97 19.16 11.19 12.32 11.92 15.48 15.82 17.11 Depreciation 35.71 34.34 31.52 32.13 32.15 22.28 22.07 19.27 19.90 19.18 19.43 PBT 95.39 93.32 66.33 5.55 68.65 91.12 50.76 62.35 60.35 41.58 56.27 Tax 25.13 24.94 16.91 1.47 0.62 30.16 18.07 20.90 19.89 5.97 14.63 Tax Rate 26.34% 26.73% 25.49% 26.49% 0.90% 33.10% 35.60% 33.52% 32.96% 14.36% 26.00% PAT 70.26 68.38 49.42 4.08 68.04 60.96 32.69 41.45 40.45 35.61 41.64 PAT before Minority Interest 70.26 68.38 49.42 4.08 68.04 60.96 32.69 41.45 40.45 35.61 41.64 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 8.63% 8.74% 6.97% 0.78% 13.09% 10.82% 7.94% 8.92% 8.70% 7.99% 6.81% PAT Growth 24.42% 38.37% 1,111.27% -94.00% 11.61% 86.48% -21.13% 2.47% 13.59% -14.48% EPS 7.92 7.71 5.57 0.46 7.67 6.87 3.69 4.67 4.56 4.01 4.69

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 814.35 782.75 709.26 522.05 519.87 563.18 411.95 464.91 464.93 445.49 611.53 Net Sales Growth 10.29% 10.36% 35.86% 0.42% -7.69% 36.71% -11.39% 0.00% 4.36% -27.15% Cost Of Goods Sold 460.07 437.06 424.26 335.80 275.45 340.00 246.36 292.71 289.90 295.85 385.15 Gross Profit 354.28 345.69 285.00 186.24 244.43 223.18 165.59 172.20 175.03 149.64 226.38 GP Margin 43.50% 44.16% 40.18% 35.67% 47.02% 39.63% 40.20% 37.04% 37.65% 33.59% 37.02% Total Expenditure 669.49 643.76 592.50 467.52 405.26 442.04 331.92 374.77 371.59 370.35 522.32 Power & Fuel Cost - 56.76 47.12 35.97 32.58 23.31 18.99 21.75 22.57 18.23 33.81 % Of Sales - 7.25% 6.64% 6.89% 6.27% 4.14% 4.61% 4.68% 4.85% 4.09% 5.53% Employee Cost - 69.72 56.78 50.08 51.02 41.17 39.35 35.59 32.80 26.92 38.11 % Of Sales - 8.91% 8.01% 9.59% 9.81% 7.31% 9.55% 7.66% 7.05% 6.04% 6.23% Manufacturing Exp. - 42.85 37.87 28.08 25.80 16.28 14.89 13.29 12.14 10.35 37.94 % Of Sales - 5.47% 5.34% 5.38% 4.96% 2.89% 3.61% 2.86% 2.61% 2.32% 6.20% General & Admin Exp. - 22.46 20.68 12.48 15.32 14.93 8.05 8.69 8.45 9.00 10.51 % Of Sales - 2.87% 2.92% 2.39% 2.95% 2.65% 1.95% 1.87% 1.82% 2.02% 1.72% Selling & Distn. Exp. - 13.75 4.73 3.82 3.42 5.09 3.70 2.25 4.81 9.67 15.99 % Of Sales - 1.76% 0.67% 0.73% 0.66% 0.90% 0.90% 0.48% 1.03% 2.17% 2.61% Miscellaneous Exp. - 1.17 1.07 1.27 1.67 1.25 0.58 0.49 0.91 0.33 15.99 % Of Sales - 0.15% 0.15% 0.24% 0.32% 0.22% 0.14% 0.11% 0.20% 0.07% 0.13% EBITDA 144.86 138.99 116.76 54.53 114.61 121.14 80.03 90.14 93.34 75.14 89.21 EBITDA Margin 17.79% 17.76% 16.46% 10.45% 22.05% 21.51% 19.43% 19.39% 20.08% 16.87% 14.59% Other Income 5.45 6.22 4.46 4.91 5.20 3.45 5.11 3.40 2.39 1.45 3.61 Interest 19.71 18.54 23.60 21.97 19.16 11.19 12.32 11.92 15.48 15.82 17.11 Depreciation 35.71 34.34 31.52 32.13 32.15 22.28 22.07 19.27 19.90 19.18 19.43 PBT 94.87 92.34 66.11 5.35 68.50 91.12 50.76 62.35 60.35 41.58 56.27 Tax 25.13 24.94 16.91 1.47 0.62 30.16 18.07 20.90 19.89 5.97 14.63 Tax Rate 26.49% 27.01% 25.58% 27.48% 0.91% 33.10% 35.60% 33.52% 32.96% 14.36% 26.00% PAT 69.73 67.40 49.20 3.88 67.88 60.96 32.69 41.45 40.45 35.61 41.64 PAT before Minority Interest 69.73 67.40 49.20 3.88 67.88 60.96 32.69 41.45 40.45 35.61 41.64 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 8.56% 8.61% 6.94% 0.74% 13.06% 10.82% 7.94% 8.92% 8.70% 7.99% 6.81% PAT Growth 22.85% 36.99% 1,168.04% -94.28% 11.35% 86.48% -21.13% 2.47% 13.59% -14.48% EPS 7.86 7.60 5.55 0.44 7.65 6.87 3.69 4.67 4.56 4.01 4.69

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 673.07 570.49 495.10 493.76 428.22 367.42 339.92 301.11 262.63 294.36 Share Capital 8.87 8.47 8.47 8.47 8.47 8.47 8.47 8.47 8.47 8.47 Total Reserves 648.33 533.45 486.63 485.30 419.76 358.96 331.46 292.64 254.17 285.90 Non-Current Liabilities 188.67 166.05 164.17 192.73 206.26 114.47 94.35 96.58 91.41 161.56 Secured Loans 138.16 120.89 119.93 148.30 146.21 67.02 61.01 70.20 73.02 109.58 Unsecured Loans 1.20 1.20 1.20 1.20 1.20 1.20 1.20 1.20 1.20 3.64 Long Term Provisions 1.21 1.16 1.40 1.57 1.84 1.73 1.52 2.18 1.35 3.43 Current Liabilities 344.50 346.72 254.97 211.48 211.43 154.21 156.05 134.29 156.00 200.43 Trade Payables 113.91 151.32 107.43 72.86 65.44 44.49 47.70 39.27 66.75 84.40 Other Current Liabilities 84.54 65.37 52.65 54.69 58.31 38.84 23.32 22.91 19.95 40.37 Short Term Borrowings 124.80 114.00 93.79 67.91 70.86 61.16 70.81 58.40 59.76 72.75 Short Term Provisions 21.24 16.03 1.10 16.02 16.82 9.72 14.22 13.71 9.54 2.90 Total Liabilities 1,206.24 1,083.26 914.24 897.97 845.91 636.10 590.32 531.98 510.04 656.35 Net Block 532.98 437.26 412.02 437.99 457.36 280.49 281.26 279.26 290.45 370.35 Gross Block 760.33 630.61 575.55 569.62 558.80 360.77 339.57 318.34 309.63 433.08 Accumulated Depreciation 227.35 193.35 163.53 131.63 101.44 80.29 58.31 39.08 19.18 62.73 Non Current Assets 631.64 534.36 503.54 505.92 520.58 408.32 369.23 350.66 343.68 408.79 Capital Work in Progress 34.67 30.27 33.19 11.00 6.74 42.12 18.30 8.20 7.76 12.80 Non Current Investment 45.11 45.10 45.10 45.00 45.00 45.00 45.00 45.00 36.98 21.27 Long Term Loans & Adv. 15.94 19.04 10.70 9.32 9.10 38.47 22.55 16.19 6.58 4.37 Other Non Current Assets 2.95 2.69 2.54 2.61 2.38 2.25 2.13 2.01 1.90 0.00 Current Assets 574.60 548.89 410.70 392.05 325.33 227.78 221.09 181.32 166.36 247.55 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 284.73 233.70 223.50 251.10 137.79 129.20 136.40 107.48 92.52 112.68 Sundry Debtors 203.23 236.23 148.35 48.52 105.68 48.77 26.02 24.15 21.32 61.09 Cash & Bank 41.58 36.20 7.47 46.66 40.51 9.65 14.88 12.71 12.37 15.08 Other Current Assets 45.05 6.77 6.00 6.39 41.35 40.16 43.79 36.98 40.15 58.70 Short Term Loans & Adv. 36.61 35.99 25.39 39.39 22.17 19.20 17.06 14.89 11.67 23.49 Net Current Assets 230.10 202.18 155.74 180.57 113.90 73.57 65.04 47.03 10.36 47.13 Total Assets 1,206.24 1,083.25 914.24 897.97 845.91 636.10 590.32 531.98 510.04 656.34

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 639.64 536.33 460.53 470.29 410.53 348.24 321.92 284.49 254.74 293.60 Share Capital 8.87 8.47 8.47 8.47 8.47 8.47 8.47 8.47 8.47 8.47 Total Reserves 614.90 499.29 452.06 461.82 402.06 339.77 313.45 276.02 246.28 285.14 Non-Current Liabilities 188.67 166.05 164.17 192.73 206.26 114.47 94.35 96.58 91.41 161.56 Secured Loans 138.16 120.89 119.93 148.30 146.21 67.02 61.01 70.20 73.02 109.58 Unsecured Loans 1.20 1.20 1.20 1.20 1.20 1.20 1.20 1.20 1.20 3.64 Long Term Provisions 1.21 1.16 1.40 1.57 1.84 1.73 1.52 2.18 1.35 3.43 Current Liabilities 344.50 346.72 254.97 211.48 211.43 154.21 156.05 134.29 156.00 200.43 Trade Payables 113.92 151.32 107.43 72.86 65.44 44.49 47.70 39.27 66.75 84.40 Other Current Liabilities 84.54 65.37 52.65 54.69 58.31 38.84 23.32 22.91 19.95 40.37 Short Term Borrowings 124.80 114.00 93.79 67.91 70.86 61.16 70.81 58.40 59.76 72.75 Short Term Provisions 21.24 16.03 1.10 16.02 16.82 9.72 14.22 13.71 9.54 2.90 Total Liabilities 1,172.81 1,049.10 879.67 874.50 828.22 616.92 572.32 515.36 502.15 655.59 Net Block 532.98 437.26 412.02 437.99 457.36 280.49 281.26 279.26 290.45 370.35 Gross Block 760.33 630.61 575.55 569.62 558.80 360.77 339.57 318.34 309.63 500.81 Accumulated Depreciation 227.35 193.35 163.53 131.63 101.44 80.29 58.31 39.08 19.18 130.46 Non Current Assets 598.21 500.20 468.96 482.45 502.88 389.13 351.22 334.04 335.80 408.04 Capital Work in Progress 34.67 30.27 33.19 11.00 6.74 42.12 18.30 8.20 7.76 12.80 Non Current Investment 11.68 10.94 10.52 21.53 27.30 25.81 26.99 28.38 29.10 20.51 Long Term Loans & Adv. 15.94 19.04 10.70 9.32 9.10 38.47 22.55 16.19 6.58 4.37 Other Non Current Assets 2.95 2.69 2.54 2.61 2.38 2.25 2.13 2.01 1.90 0.00 Current Assets 574.60 548.89 410.70 392.05 325.33 227.78 221.09 181.32 166.36 247.55 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 284.73 233.70 223.50 251.10 137.79 129.20 136.40 107.48 92.52 112.68 Sundry Debtors 203.23 236.23 148.35 48.52 105.68 48.77 26.02 24.15 21.32 61.09 Cash & Bank 41.59 36.20 7.47 46.66 40.51 9.65 14.88 12.71 12.37 15.08 Other Current Assets 45.05 6.77 6.00 6.39 41.35 40.16 43.79 36.98 40.15 58.70 Short Term Loans & Adv. 36.61 35.99 25.39 39.39 22.17 19.20 17.06 14.89 11.67 23.49 Net Current Assets 230.10 202.18 155.74 180.57 113.90 73.57 65.04 47.03 10.36 47.13 Total Assets 1,172.81 1,049.09 879.66 874.50 828.21 616.91 572.31 515.36 502.16 655.59

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 81.71 50.12 22.45 45.06 90.45 39.71 49.76 31.81 73.47 61.22 PBT 93.32 66.33 5.55 68.65 91.12 50.76 62.35 60.35 41.58 56.27 Adjustment 51.31 53.74 52.79 49.70 27.76 28.66 26.81 31.08 31.58 28.14 Changes in Working Capital -43.08 -54.55 -31.29 -58.38 -12.38 -27.60 -26.02 -48.48 9.40 -1.17 Cash after chg. in Working capital 101.55 65.52 27.05 59.98 106.50 51.82 63.14 42.95 82.56 83.24 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -19.83 -15.40 -4.60 -14.92 -16.05 -12.10 -13.38 -11.14 -9.09 -22.02 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -123.44 -52.07 -29.76 -27.15 -151.59 -42.56 -34.67 -16.58 -38.96 -96.72 Net Fixed Assets -134.12 -52.14 -28.12 -15.08 -162.65 -45.02 -31.33 -9.15 128.49 -28.01 Net Investments -0.01 0.00 -0.10 0.00 0.00 0.00 0.00 -8.02 -15.71 -8.04 Others 10.69 0.07 -1.54 -12.07 11.06 2.46 -3.34 0.59 -151.74 -60.67 Cash from Financing Activity 47.08 30.68 -31.97 -11.75 92.02 -2.40 -12.92 -14.89 -33.19 44.34 Net Cash Inflow / Outflow 5.35 28.73 -39.27 6.16 30.88 -5.25 2.17 0.35 1.32 8.84 Opening Cash & Equivalents 36.04 7.31 46.58 40.42 9.54 14.80 12.63 12.29 11.25 2.41 Closing Cash & Equivalent 41.39 36.04 7.31 46.58 40.42 9.54 14.80 12.63 12.29 11.25

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 81.71 50.12 22.45 45.06 90.45 39.71 49.76 31.81 73.47 61.22 PBT 92.34 66.11 5.35 68.50 91.12 50.76 62.35 60.35 41.58 56.27 Adjustment 52.28 53.97 52.99 49.86 27.76 28.66 26.81 31.08 31.58 28.14 Changes in Working Capital -43.08 -54.55 -31.29 -58.38 -12.38 -27.60 -26.02 -48.48 9.40 -1.17 Cash after chg. in Working capital 101.54 65.52 27.05 59.98 106.50 51.82 63.14 42.95 82.56 83.24 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -19.83 -15.40 -4.60 -14.92 -16.05 -12.10 -13.38 -11.14 -9.09 -22.02 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -123.43 -52.07 -29.76 -27.15 -151.59 -42.56 -34.67 -16.58 -38.96 -96.72 Net Fixed Assets -134.12 -52.14 -28.12 -15.08 -162.65 -45.02 -31.33 -9.15 128.49 -346.44 Net Investments -0.01 0.00 -0.10 0.00 0.00 0.00 0.00 -8.02 -15.71 -17.94 Others 10.70 0.07 -1.54 -12.07 11.06 2.46 -3.34 0.59 -151.74 267.66 Cash from Financing Activity 47.08 30.68 -31.97 -11.75 92.02 -2.40 -12.92 -14.89 -33.19 44.34 Net Cash Inflow / Outflow 5.36 28.73 -39.27 6.16 30.88 -5.25 2.17 0.35 1.32 8.84 Opening Cash & Equivalents 36.04 7.31 46.58 40.42 9.54 14.80 12.63 12.29 11.25 2.41 Closing Cash & Equivalent 41.40 36.04 7.31 46.58 40.42 9.54 14.80 12.63 12.29 11.25

Financial Ratios

Consolidated /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 74.13 64.02 58.49 58.33 50.59 43.40 40.16 35.57 31.02 34.77 ROA 5.97% 4.95% 0.45% 7.80% 8.23% 5.33% 7.39% 7.76% 6.11% 6.96% ROE 11.41% 9.53% 0.83% 14.76% 15.32% 9.24% 12.93% 14.35% 12.79% 15.17% ROCE 12.20% 11.25% 3.67% 12.26% 17.07% 12.57% 15.96% 17.66% 12.61% 15.95% Fixed Asset Turnover 1.22 1.27 0.97 0.98 1.32 1.29 1.53 1.59 1.22 1.53 Receivable days 94.73 91.77 65.01 50.80 46.40 30.27 18.23 16.66 33.12 34.86 Inventory Days 111.76 109.10 156.71 128.12 80.21 107.49 88.61 73.28 82.47 57.59 Payable days 111.00 111.36 98.04 91.68 59.01 46.62 40.24 46.81 71.90 49.65 Cash Conversion Cycle 95.49 89.51 123.68 87.24 67.61 91.14 66.60 43.12 43.69 42.80 Total Debt/Equity 0.47 0.52 0.51 0.53 0.59 0.41 0.42 0.49 0.57 0.69 Interest Cover 6.03 3.81 1.25 4.58 9.14 5.12 6.23 4.90 3.63 4.29

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 70.36 59.98 54.40 55.56 48.50 41.14 38.03 33.61 30.09 34.68 ROA 6.07% 5.10% 0.44% 7.97% 8.44% 5.50% 7.62% 7.95% 6.15% 8.46% ROE 11.91% 10.16% 0.83% 15.41% 16.07% 9.76% 13.67% 15.00% 12.99% 17.57% ROCE 12.55% 11.73% 3.79% 12.60% 17.62% 13.06% 16.57% 18.17% 12.73% 19.54% Fixed Asset Turnover 1.22 1.27 0.97 0.98 1.32 1.29 1.53 1.59 1.12 2.11 Receivable days 94.73 91.77 65.01 50.80 46.40 30.27 18.23 16.66 33.12 35.09 Inventory Days 111.76 109.10 156.71 128.12 80.21 107.49 88.61 73.28 82.47 47.02 Payable days 110.75 111.30 97.98 91.63 59.01 46.62 40.24 46.81 71.90 36.96 Cash Conversion Cycle 95.74 89.57 123.74 87.30 67.61 91.14 66.60 43.12 43.69 45.14 Total Debt/Equity 0.50 0.55 0.55 0.55 0.61 0.44 0.45 0.51 0.59 0.70 Interest Cover 5.98 3.80 1.24 4.57 9.14 5.12 6.23 4.90 3.63 4.29

Top Investors:

quant mutual fund - quant small cap fund

venkata subbaraju penmatsa (huf)

sudeepthi gopineedi

venkata praveen talluri

vivek mundra

aniruddh mundra

investor education and protection fund (iepf)

Annual Reports:

News Update:

SMS Pharmaceuticals gets EIR for Central Laboratory Analytical Services
28th Aug 2025, 12:50 PM

The company has received the EIR with ‘No Action Indicated’ status
Read More
SMS Pharmaceuticals - Quarterly Results
9th Aug 2025, 13:32 PM

Read More

SMS Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - API

BSE: 532815 | NSE: SMSPHARMA

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

SMS Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - API

BSE: 532815 | NSE: SMSPHARMA

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: